drugset / Trial / NCT03183024
Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody
Non-randomizedParallel-groupSingle-blindTreatment
Summary
Study to determine the efficacy of benralizumab when compared to placebo in patients with chronic hives that do not respond to antihistamine treatment
Timeline
- Start
- 2017-09-12
- Primary completion
- 2018-11-06
- Completion
- 2018-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benralizumab | Monoclonal antibody | — | Subcutaneous |